JP2023537271A5 - - Google Patents

Info

Publication number
JP2023537271A5
JP2023537271A5 JP2023504724A JP2023504724A JP2023537271A5 JP 2023537271 A5 JP2023537271 A5 JP 2023537271A5 JP 2023504724 A JP2023504724 A JP 2023504724A JP 2023504724 A JP2023504724 A JP 2023504724A JP 2023537271 A5 JP2023537271 A5 JP 2023537271A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
heterocycloalkyl
heteroaryl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023504724A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023537271A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/042960 external-priority patent/WO2022020714A1/en
Publication of JP2023537271A publication Critical patent/JP2023537271A/ja
Publication of JP2023537271A5 publication Critical patent/JP2023537271A5/ja
Pending legal-status Critical Current

Links

JP2023504724A 2020-07-24 2021-07-23 チオフェンhsd17b13阻害剤とその使用 Pending JP2023537271A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063056165P 2020-07-24 2020-07-24
US63/056,165 2020-07-24
US202063113555P 2020-11-13 2020-11-13
US63/113,555 2020-11-13
PCT/US2021/042960 WO2022020714A1 (en) 2020-07-24 2021-07-23 Thiophene hsd17b13 inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2023537271A JP2023537271A (ja) 2023-08-31
JP2023537271A5 true JP2023537271A5 (enExample) 2024-07-18

Family

ID=79729016

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023504724A Pending JP2023537271A (ja) 2020-07-24 2021-07-23 チオフェンhsd17b13阻害剤とその使用

Country Status (6)

Country Link
US (1) US20230278978A1 (enExample)
EP (1) EP4185381A4 (enExample)
JP (1) JP2023537271A (enExample)
CN (1) CN116323578A (enExample)
TW (1) TW202220967A (enExample)
WO (1) WO2022020714A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4244210A4 (en) 2020-11-13 2024-10-30 Inipharm, Inc. Dichlorophenol hsd17b13 inhibitors and uses thereof
US12617772B2 (en) 2021-04-05 2026-05-05 Inipharm, Inc. Hydroxypyridine HSD17B13 inhibitors and uses thereof
JP2024534799A (ja) 2021-08-20 2024-09-26 エナンタ ファーマシューティカルズ インコーポレイテッド 17-ベータ-ヒドロキシステロイドデヒドロゲナーゼ13型阻害剤及びその使用方法
KR20240122834A (ko) * 2021-12-15 2024-08-13 브리스톨-마이어스 스큅 컴퍼니 Rxfp1 효능제로서의 벤조티오펜 유도체
AU2023213627A1 (en) * 2022-01-26 2024-08-15 Inipharm, Inc. 2-substituted thiazole hsd17b13 inhibitors and uses thereof
EP4514782B1 (en) 2022-05-19 2025-09-10 Astrazeneca AB Amido heteroaromatic compounds useful in the treatment of liver diseases
WO2023237504A1 (en) 2022-06-09 2023-12-14 Boehringer Ingelheim International Gmbh Hsd17b13 inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19642451A1 (de) * 1996-10-15 1998-04-16 Merck Patent Gmbh Aminothiophencarbonsäureamide
WO2004085382A1 (ja) * 2003-03-27 2004-10-07 Kirin Beer Kabushiki Kaisha 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
CA2583259C (en) * 2004-10-08 2011-08-02 Astellas Pharma Inc. Aromatic ring fused pyrimidine derivative
GB0513702D0 (en) * 2005-07-04 2005-08-10 Sterix Ltd Compound
US7446195B2 (en) * 2005-08-17 2008-11-04 Schering Corporation High affinity thiophene-based and furan-based kinase ligands
AU2011272782B2 (en) * 2010-07-02 2014-11-27 Gilead Sciences, Inc. Apoptosis signal-regulating kinase inhibitors
JP2014514257A (ja) * 2011-03-03 2014-06-19 ユニバーシテーテ デス ザールランデス 選択的17ベータ−ヒドロキシステロイドデヒドロゲナーゼ2型阻害剤としてのビアリール誘導体
ES2929283T3 (es) * 2012-05-04 2022-11-28 Us Health Moduladores del receptor de relaxina 1
CN105524053B (zh) * 2014-10-19 2020-06-05 广东东阳光药业有限公司 四氢苯并噻吩化合物
ES2969565T3 (es) * 2015-09-30 2024-12-13 Max Planck Ges Zur Foerderung Derwissenschaften E V Derivados heteroarílicos como inhibidores de la sepiapterina reductasa
KR101870968B1 (ko) * 2016-02-02 2018-06-25 부산대학교 산학협력단 Ppar, fxr 및 ampk 활성화 효능을 갖는 신규 티오펜 화합물 또는 이의 약제학적으로 허용 가능한 염 및 이의 의학적 용도
CA3033628C (en) * 2016-08-15 2021-01-12 Eli Lilly And Company Condensed thiophene derivatives useful as napi-iib inhibitors
WO2018204775A1 (en) * 2017-05-05 2018-11-08 Hepanova, Inc. Amino-aryl-benzamide compounds and methods of use thereof
IL275893B2 (en) * 2018-02-08 2024-08-01 Enyo Pharma The history of unfused thiophene and their uses
CA3093547A1 (en) * 2018-03-21 2019-09-26 Ionis Pharmaceuticals, Inc. Modulation of hsd17b13 expression

Similar Documents

Publication Publication Date Title
JP2023535453A5 (enExample)
JP2024520481A5 (enExample)
JP2022545633A5 (enExample)
JP2022505987A5 (enExample)
JP2021524838A5 (enExample)
JP2008510691A5 (enExample)
JP2017524025A5 (enExample)
JP2023553835A5 (enExample)
RU2017112048A (ru) Синергистические комбинации ауристана
JP2018509409A5 (enExample)
JP2018504437A5 (enExample)
JP2021527125A5 (enExample)
JP2017527532A5 (enExample)
JP2013532652A5 (enExample)
JP2019522055A5 (enExample)
JP2025503953A5 (enExample)
JP2025507292A5 (enExample)
JP2012519691A5 (enExample)
JP2017536395A5 (enExample)
JP2022137237A5 (enExample)
JP2019510027A5 (enExample)
JP2009536221A5 (enExample)
JP2022141692A5 (enExample)
RU2017105743A (ru) Модифицированные олигонуклеотиды, активирующие рнказу н
JP2005530811A5 (enExample)